STANDARD BIOTOOLS INC. — Director's Dealing 2013

Mar 6, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2013-03-04

Reporting Person: Yow Mai Chan (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-04	Common Stock	M	2673	$4.0828	Acquired	2673	Direct
2013-03-04	Common Stock	S	2673	$17.7502	Disposed	0	Direct
2013-03-04	Common Stock	M	27327	$4.4461	Acquired	27327	Direct
2013-03-04	Common Stock	S	27327	$18.1867	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-04	Employee Stock Option (Right to Buy)	$4.0828	M	361	Disposed	2019-11-17	Common Stock (361)	Direct
2013-03-04	Employee Stock Option (Right to Buy)	$4.0828	M	2312	Disposed	2019-11-17	Common Stock (2312)	Direct
2013-03-04	Employee Stock Option (Right to Buy)	$4.4461	M	4744	Disposed	2017-05-07	Common Stock (4744)	Direct
2013-03-04	Employee Stock Option (Right to Buy)	$4.4461	M	8257	Disposed	2018-04-23	Common Stock (8257)	Direct
2013-03-04	Employee Stock Option (Right to Buy)	$4.4461	M	8257	Disposed	2018-04-23	Common Stock (8257)	Direct
2013-03-04	Employee Stock Option (Right to Buy)	$4.4461	M	6069	Disposed	2018-04-23	Common Stock (6069)	Direct

Footnotes

F1: The sales reported by Ms. Yow were effected pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2013.

F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $17.38 to $17.7933, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $17.40 to $18.56, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F4: 70% of the shares subject to the Option vested on December 31, 2009, 25% of the remaining 30% of the shares subject to the Option vested on April 1, 2010 and 1/48th of the remaining unvested shares subject to the Option shall vest each month thereafter.

F5: The shares subject to the Option fully vested on December 31, 2012.

F6: 100% of the shares subject to the Option vested on May 1, 2010.

F7: The shares subject to the Option fully vested on May 1, 2012.

F8: The shares subject to the Option fully vested on March 31, 2012.

F9: 100% of the shares subject to the Option vested on March 22, 2010.